HBI
56
3
NDAQ
50
4
KLAC
59
3
RIG
35
6
MTCH
57
2
HCP
56
2
EQIX
59
2
HES
53
4
FLR
52
2
IPG
42
2
VIX
7
-18
CPB
27
5
MA
64
2
NTAP
60
2
PLD
40
2
JNPR
62
2
APH
58
5
CHRW
54
3
DGX
29
2
GOOG
83
4
HBI
56
3
NDAQ
50
4
KLAC
59
3
RIG
35
6
MTCH
57
2
HCP
56
2
EQIX
59
2
HES
53
4
FLR
52
2
IPG
42
2
VIX
7
-18
CPB
27
5
MA
64
2
NTAP
60
2
PLD
40
2
JNPR
62
2
APH
58
5
CHRW
54
3
DGX
29
2
GOOG
83
4
Financhill
Back

Alaunos Therapeutics 10K Form

Sell
27

TCRT
Alaunos Therapeutics

Last Price:
$1.90
Seasonality Move:
26.55%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TCRT News And Ratings

See the #1 stock for the next 7 days that we like better than TCRT

TCRT Financial Statistics

Sales & Book Value

Annual Sales: $5K
Cash Flow: $-781K
Price / Cash Flow: 0
Annual Sales: $1.70
Price / Book: 1.15

Profitability

EPS (TTM): -7.40800
Net Income (TTM): $-11.8M
Gross Margin: $0
Return on Equity: -189.69%
Return on Assets: -144.17%

Alaunos Therapeutics Earnings Forecast

Key Alaunos Therapeutics Financial Ratios

  • The Selling, General & Administrative Expenses for TCRT have been equal to 244,380.00% of Gross Profit Margin.
  • The Research & Development expenses have been 325,580.00% of Revenue.
  • The Interest Expense is -5.47% of Operating Income.
  • The Net Earning history of TCRT is -702,800.00% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 13 years.

Alaunos Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: TCRT
Website: alaunos.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.16
Quick Ratio: 2.72

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TCRT Technical Analysis vs Fundamental Analysis

Sell
27
Alaunos Therapeutics (TCRT) is a Sell

Is Alaunos Therapeutics a Buy or a Sell?